NIH Advisors Back Insuring Complementary, Alternative Solutions To Drugs For Health Care
This article was originally published in The Rose Sheet
Executive Summary
Consumers with chronic pain spend less in co-pays for pain medications than they would for natural remedies or treatments such as chiropractic or acupuncture because few insurance plans pay for alternative care, NIH advisory committee members say.
You may also be interested in...
Opioid Approval Standards Not Up For Debate, FDA Tells Advisory Cmte.
As Egalet's Arymo ER heads to panel, agency tries to head off discussion about whether it should be approving new opioid products and whether longer clinical efficacy trials should be demanded.
Can Insurers Curb Opioid Abuse? CDC Puts Spotlight On Payers
As Medicare emerges as the dominant payer for opioids, CDC urges research into how government and private payers could best employ prior authorization and drug utilization reviews.
Supplement Health Care Cost Savings Movement Faces Long Road
A CRN-funded report says specific supplement regimens could save the health care system billions, but the path to creating and funding dietary supplement programs for disease prevention is fraught with obstacles, including additional costs, political controversy and reticence to change by firms and insurers, experts say.